Dr. Robin Shattock, PhD, is a Professor of Mucosal Infection and Immunity at Imperial College, London. The main focus of his research is the investigation of the mechanisms of mucosal HIV transmission and development of novel preventative strategies. His group has a strong interest in mucosal immune responses to infection and vaccination with active programs on HIV, Ebola, Lassa, Marburg and Chlamydia. Dr. Shattock has secured funding from the MRC-UK, European Commission, NIH and the Bill and Melinda Gates Foundation. He is the scientific director of the European AIDS Vaccine Initiative (EAVI2020) that coordinates a program of EU funded vaccine research across 22 institutions. His research team is leading a range of Experimental Medicine clinical trials of candidate HIV vaccines. Dr. Shattock chairs the Research and Advisory Steering Committee of the International Partnership for Microbicides and is a member of the Scientific Advisory board of the International AIDS Vaccine Initiative (IAVI).